ZA934995B - Preparation of form 1 ranitidine hydrochloride - Google Patents

Preparation of form 1 ranitidine hydrochloride

Info

Publication number
ZA934995B
ZA934995B ZA934995A ZA934995A ZA934995B ZA 934995 B ZA934995 B ZA 934995B ZA 934995 A ZA934995 A ZA 934995A ZA 934995 A ZA934995 A ZA 934995A ZA 934995 B ZA934995 B ZA 934995B
Authority
ZA
South Africa
Prior art keywords
ranitidine hydrochloride
preparation
prepared
volume
solution
Prior art date
Application number
ZA934995A
Other languages
English (en)
Inventor
Teng-Ko Ngooi
Jeffry David Mcgolrick
Casimir Antczak
James Lorne Anthony Tindall
Original Assignee
Torcan Chemical Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US08/041,354 priority Critical patent/US5338871A/en
Priority to AT93304182T priority patent/ATE119894T1/de
Priority to ES93304182T priority patent/ES2069446T3/es
Priority to EP93304182A priority patent/EP0626381B1/en
Priority to DK93304182.4T priority patent/DK0626381T3/da
Priority to DE69300088T priority patent/DE69300088T2/de
Priority to CA002099530A priority patent/CA2099530C/en
Priority to AU41794/93A priority patent/AU674006B2/en
Priority to HU9301980A priority patent/HU214334B/hu
Application filed by Torcan Chemical Limited filed Critical Torcan Chemical Limited
Priority to ZA934995A priority patent/ZA934995B/xx
Priority to CN93109329A priority patent/CN1048984C/zh
Publication of ZA934995B publication Critical patent/ZA934995B/xx
Priority to NZ260551A priority patent/NZ260551A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
ZA934995A 1991-12-20 1993-07-12 Preparation of form 1 ranitidine hydrochloride ZA934995B (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
US08/041,354 US5338871A (en) 1991-12-20 1993-04-01 Preparation of form 1 ranitidine hydrochloride
ES93304182T ES2069446T3 (es) 1993-04-01 1993-05-28 Preparacion de hidrocloruro de ranitidina en forma 1.
EP93304182A EP0626381B1 (en) 1993-04-01 1993-05-28 Preparation of form 1 ranitidine hydrochloride
DK93304182.4T DK0626381T3 (da) 1993-04-01 1993-05-28 Fremstilling af form 1 ranitidinhydrochlorid
DE69300088T DE69300088T2 (de) 1993-04-01 1993-05-28 Herstellung der Form 1 von Ranitidin Hydrochlorid.
AT93304182T ATE119894T1 (de) 1993-04-01 1993-05-28 Herstellung der form 1 von ranitidin hydrochlorid.
CA002099530A CA2099530C (en) 1993-04-01 1993-07-02 Preparation of form 1 ranitidine hydrochloride
AU41794/93A AU674006B2 (en) 1993-04-01 1993-07-06 Preparation of form 1 ranitidine hydrochloride
HU9301980A HU214334B (hu) 1993-04-01 1993-07-08 Eljárás ranitidin-hidroklorid 1 kristályformájának előállítására
ZA934995A ZA934995B (en) 1993-04-01 1993-07-12 Preparation of form 1 ranitidine hydrochloride
CN93109329A CN1048984C (zh) 1991-12-20 1993-08-10 晶形1呋喃硝胺氢氯化物的制备
NZ260551A NZ260551A (en) 1993-04-01 1994-05-18 Preparation of form 1 ranitidine hcl crystals

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US08/041,354 US5338871A (en) 1991-12-20 1993-04-01 Preparation of form 1 ranitidine hydrochloride
EP93304182A EP0626381B1 (en) 1993-04-01 1993-05-28 Preparation of form 1 ranitidine hydrochloride
CA002099530A CA2099530C (en) 1993-04-01 1993-07-02 Preparation of form 1 ranitidine hydrochloride
AU41794/93A AU674006B2 (en) 1993-04-01 1993-07-06 Preparation of form 1 ranitidine hydrochloride
HU9301980A HU214334B (hu) 1993-04-01 1993-07-08 Eljárás ranitidin-hidroklorid 1 kristályformájának előállítására
ZA934995A ZA934995B (en) 1993-04-01 1993-07-12 Preparation of form 1 ranitidine hydrochloride
NZ260551A NZ260551A (en) 1993-04-01 1994-05-18 Preparation of form 1 ranitidine hcl crystals

Publications (1)

Publication Number Publication Date
ZA934995B true ZA934995B (en) 1994-02-11

Family

ID=27560579

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA934995A ZA934995B (en) 1991-12-20 1993-07-12 Preparation of form 1 ranitidine hydrochloride

Country Status (11)

Country Link
US (1) US5338871A (xx)
EP (1) EP0626381B1 (xx)
AT (1) ATE119894T1 (xx)
AU (1) AU674006B2 (xx)
CA (1) CA2099530C (xx)
DE (1) DE69300088T2 (xx)
DK (1) DK0626381T3 (xx)
ES (1) ES2069446T3 (xx)
HU (1) HU214334B (xx)
NZ (1) NZ260551A (xx)
ZA (1) ZA934995B (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4341310A1 (de) * 1993-12-03 1995-06-08 Hexal Pharma Gmbh Tablette oder Kapsel mit einem Gehalt an stabilem Ranitidinhydrochlorid Form 1
CA2120874E (en) * 1994-04-08 2002-01-08 Keshava Murthy Form of form 1 ranitidine
IN181699B (xx) * 1994-05-13 1998-09-05 Ranbaxy Lab Ltd
NZ272054A (en) * 1994-05-13 1996-05-28 Ranbaxy Lab Ltd Process for producing form 1 ranitidine hydrochloride
EP0694540B1 (en) * 1994-06-24 1998-08-19 Ranbaxy Laboratories Limited Process for the manufacture of form 1 ranitidine hydrochloride
WO1996019232A1 (en) * 1994-12-19 1996-06-27 Lauteral Limited Combinations of ranitidine hydrochloride-form 1 and bismuth compounds
US5663381A (en) * 1995-04-21 1997-09-02 Hexal Pharmaceuticals, Inc. Process for preparing form 1 ranitidine hydrochloride
US5686588A (en) * 1995-08-16 1997-11-11 Yoo; Seo Hong Amine acid salt compounds and process for the production thereof
EP1384711A1 (en) * 1996-06-13 2004-01-28 SUMIKA FINE CHEMICALS Co., Ltd. Optical resolution of a piperidine derivative
US20020151729A1 (en) * 1997-02-26 2002-10-17 Cheng Wen J. Novel process for the preparation of form 1 ranitidine hydrochloride
IE990387A1 (en) * 1998-06-17 2000-12-13 Russinsky Ltd A ranitidine base water adduct
IT1317858B1 (it) * 2000-02-29 2003-07-15 Pharmexcel S R L Allomorfo del cloridrato dell'isomero z di derivato dialchilamminofurano, procedimento per la sua produzione e composizione
DE102006015960A1 (de) * 2006-04-04 2007-10-11 Qiagen Gmbh Gemisch reversibel inhibierter Enzyme
WO2011160037A2 (en) * 2010-06-17 2011-12-22 Dr. Reddy's Laboratories Ltd. Process for the preparation of a single enantiomer of 3-aminopiperidine dihydrochloride
EP2929884A1 (en) 2014-04-11 2015-10-14 Sanovel Ilac Sanayi ve Ticaret A.S. Pharmaceutical combinations of dabigatran and h2-receptor antagonists
WO2015169957A1 (en) 2014-05-09 2015-11-12 Sanovel Ilac Sanayi Ve Ticaret A.S. Pharmaceutical combinations of rivaroxaban and h2-receptor antagonists

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1181084A (en) * 1980-01-08 1985-01-15 Glaxo Group Limited Process for the preparation of a furan derivative
CY1306A (en) * 1980-10-01 1985-12-06 Glaxo Group Ltd Aminoalkyl furan derivative
IL63968A (en) * 1980-10-01 1985-10-31 Glaxo Group Ltd Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
DE3211127C1 (de) * 1982-03-26 1983-08-11 Degussa Ag, 6000 Frankfurt Verfahren zur Gewinnung von S-(Carboxymethyl)-(R)-cystein und S-(Carboxymethyl)-(S)-cystein
US4613688A (en) * 1982-04-02 1986-09-23 Showa Denko Kabushiki Kaisha Optical resolution process for DL-cysteine
JPH0730064B2 (ja) * 1989-08-17 1995-04-05 協和醗酵工業株式会社 フラン誘導体

Also Published As

Publication number Publication date
CA2099530A1 (en) 1995-01-03
CA2099530C (en) 2002-10-08
DE69300088D1 (de) 1995-04-20
AU674006B2 (en) 1996-12-05
HU214334B (hu) 1998-03-02
DE69300088T2 (de) 1995-08-31
US5338871A (en) 1994-08-16
AU4179493A (en) 1995-01-27
EP0626381B1 (en) 1995-03-15
ATE119894T1 (de) 1995-04-15
HUT68736A (en) 1995-04-27
HU9301980D0 (en) 1993-09-28
DK0626381T3 (da) 1995-10-02
NZ260551A (en) 1995-02-24
EP0626381A1 (en) 1994-11-30
ES2069446T3 (es) 1995-05-01

Similar Documents

Publication Publication Date Title
ZA934995B (en) Preparation of form 1 ranitidine hydrochloride
EP0372466A3 (en) 2-amino-4 or 5-methoxycyclohexyl amides useful as analgesics
CA2067877A1 (en) Polycyclic amine compounds and their enantiomers, their method of preparation and pharmaceutical compositions in which they are present
AU1170897A (en) Novel tricyclic compounds and drug compositions containing the same
AU4869990A (en) Novel 1,2-cyclohexylaminoaryl amides useful as analgesic agents
IL96507A0 (en) Nitrogen-containing spirocycles and pharmaceutical compositions containing them
IL100740A0 (en) Biphenyl derivatives,their preparation and pharmaceutical compositions containing them
ZA932168B (en) Naphthylalkylamines, process for preparing them and pharmaceutical compositions containing them
HUT70172A (en) Novel aryl-acetamides, pharmaceutical compositions comprising them and method for producing thereof
IL86139A (en) 17-(cyclopropylamino) androst-5-en-3 ol and pharmaceutical compositions containing them, useful as c17-20 lyase inhibitors
CA2124083A1 (en) Preparation of substituted piperidines
HUT65714A (en) Stabile aquous compositions containing 5,10-methylene-tetrahydro-folic acid and process for producing 5,10-methylene-tetrahydro-folic acid/cyclodextrin inclusion compounds
CA2155323A1 (en) Novel use as anti-inflammatory agents for bis-heterocyclic compounds and pharmaceutical compositions thereof
EP0561601A3 (en) Compositions containing derivatives of succinic acylating agent or hydroxyaromatic compounds and methods of using the same
TW231289B (en) Preparation of form 1 ranitidine hydrochloride
HUT46664A (en) Process for producing new dihydropyridineamide derivatives and pharmaceutical compositions comprising these compounds
EP0388977A3 (en) Polycyclic amines useful as cerebrovascular agents
HU904582D0 (en) Process for producing amino-oligohydroxi derivatives and pharmaceutical preparatives containing those compounds
AU2729588A (en) New substituted derivatives of 20,21-dinoreburnamenine, process for preparing them and the new intermediate products so obtained, their application as drugs and the pharmaceutical compositions containing them
AU624733B2 (en) Naphthalene and tetrahydronaphthalene substituted gem- diphosphonate compounds and their use in therapy
KR950003281A (ko) 제1형 염산라니티딘의 제조방법
ES2049186A1 (es) Procedimiento para la preparacion de nuevos derivados de benzofuranil-imidazol.
IL111246A0 (en) Tricyclic compounds and pharmaceutical compositions containing them
ES2059275A1 (es) Un procedimiento para producir derivados de acidos grasos halogenofenoxi-sustituidos.
HU9302750D0 (en) 1,5,6,7-tetra hydro-4h-indasole-4-on, new pharmaceutical compositions containing said compounds and process for producing them